These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 30973672)

  • 1. Design of Natural-Product-Inspired Multitarget Ligands by Machine Learning.
    Grisoni F; Merk D; Friedrich L; Schneider G
    ChemMedChem; 2019 Jun; 14(12):1129-1134. PubMed ID: 30973672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in the total synthesis of galantamine, a natural medicine for Alzheimer's disease.
    Cheng B; Wang Q; An Y; Chen F
    Nat Prod Rep; 2024 Jul; 41(7):1060-1090. PubMed ID: 38450550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galantamine-Curcumin Hybrids as Dual-Site Binding Acetylcholinesterase Inhibitors.
    Stavrakov G; Philipova I; Lukarski A; Atanasova M; Zheleva D; Zhivkova ZD; Ivanov S; Atanasova T; Konstantinov S; Doytchinova I
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32717861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual-target compounds for Alzheimer's disease: Natural and synthetic AChE and BACE-1 dual-inhibitors and their structure-activity relationship (SAR).
    Ferreira JPS; Albuquerque HMT; Cardoso SM; Silva AMS; Silva VLM
    Eur J Med Chem; 2021 Oct; 221():113492. PubMed ID: 33984802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multitarget drugs of plants origin acting on Alzheimer's disease.
    Russo P; Frustaci A; Del Bufalo A; Fini M; Cesario A
    Curr Med Chem; 2013; 20(13):1686-93. PubMed ID: 23410167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galantamine derivatives with indole moiety: Docking, design, synthesis and acetylcholinesterase inhibitory activity.
    Atanasova M; Stavrakov G; Philipova I; Zheleva D; Yordanov N; Doytchinova I
    Bioorg Med Chem; 2015 Sep; 23(17):5382-9. PubMed ID: 26260334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on the pharmacology of galantamine.
    Villarroya M; García AG; Marco-Contelles J; López MG
    Expert Opin Investig Drugs; 2007 Dec; 16(12):1987-98. PubMed ID: 18042006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tacrine-O-protected phenolics heterodimers as multitarget-directed ligands against Alzheimer's disease: Selective subnanomolar BuChE inhibitors.
    Roldán-Peña JM; Romero-Real V; Hicke J; Maya I; Franconetti A; Lagunes I; Padrón JM; Petralla S; Poeta E; Naldi M; Bartolini M; Monti B; Bolognesi ML; López Ó; Fernández-Bolaños JG
    Eur J Med Chem; 2019 Nov; 181():111550. PubMed ID: 31376562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AChE inhibitory activity of N-substituted natural galanthamine derivatives.
    Atanasova M; Stavrakov G; Philipova I; Georgiev B; Bastida J; Doytchinova I; Berkov S
    Bioorg Med Chem Lett; 2024 Nov; 112():129937. PubMed ID: 39218406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The structural simplification of lysergic acid as a natural lead for synthesizing novel anti-Alzheimer agents.
    Alzweiri M; S Alsegiani A; Karaj E; A Almarghalani D; Tabaza Y; A Shah Z; Tillekeratne LMV
    Bioorg Med Chem Lett; 2021 Sep; 47():128205. PubMed ID: 34139326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological assessment of KojoTacrines as new agents for Alzheimer's disease therapy.
    Dgachi Y; Martin H; Malek R; Jun D; Janockova J; Sepsova V; Soukup O; Iriepa I; Moraleda I; Maalej E; Carreiras MC; Refouvelet B; Chabchoub F; Marco-Contelles J; Ismaili L
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):163-170. PubMed ID: 30482062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and evaluation of isoflavone analogs as multifunctional agents for the treatment of Alzheimer's disease.
    Wang D; Hu M; Li X; Zhang D; Chen C; Fu J; Shao S; Shi G; Zhou Y; Wu S; Zhang T
    Eur J Med Chem; 2019 Apr; 168():207-220. PubMed ID: 30822710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nature-based molecules combined with rivastigmine: A symbiotic approach for the synthesis of new agents against Alzheimer's disease.
    Nesi G; Chen Q; Sestito S; Digiacomo M; Yang X; Wang S; Pi R; Rapposelli S
    Eur J Med Chem; 2017 Dec; 141():232-239. PubMed ID: 29031070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multitarget strategies in Alzheimer's disease: benefits and challenges on the road to therapeutics.
    Rosini M; Simoni E; Caporaso R; Minarini A
    Future Med Chem; 2016 Apr; 8(6):697-711. PubMed ID: 27079260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Multitarget Hybrid Compounds for the Treatment of Alzheimer's Disease.
    Michalska P; Buendia I; Del Barrio L; Leon R
    Curr Top Med Chem; 2017; 17(9):1027-1043. PubMed ID: 27697052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial: Multitarget Molecules for Alzheimer's Disease Therapy.
    Marco-Contelles J; Fall Y
    Curr Top Med Chem; 2017; 17(31):3318. PubMed ID: 29500890
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents.
    Shaik JB; Palaka BK; Penumala M; Kotapati KV; Devineni SR; Eadlapalli S; Darla MM; Ampasala DR; Vadde R; Amooru GD
    Eur J Med Chem; 2016 Jan; 107():219-32. PubMed ID: 26588065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Synthesis of Certain Derivatives and Analogues of (-)- and (+)-Galanthamine and an Assessment of their Capacities to Inhibit Acetylcholine Esterase.
    Buckler JN; Taher ES; Fraser NJ; Willis AC; Carr PD; Jackson CJ; Banwell MG
    J Org Chem; 2017 Aug; 82(15):7869-7886. PubMed ID: 28671462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, biological evaluation, and molecular dynamics of novel cholinesterase inhibitors as anti-Alzheimer's agents.
    Shamsimeymandi R; Pourshojaei Y; Eskandari K; Mohammadi-Khanaposhtani M; Abiri A; Khodadadi A; Langarizadeh A; Sharififar F; Amirheidari B; Akbarzadeh T; Lotfian H; Foroumadi A; Asadipour A
    Arch Pharm (Weinheim); 2019 Jul; 352(7):e1800352. PubMed ID: 31136018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Static Binding and Dynamic Transporting-Based Design of Specific Ring-Chain-Ring Acetylcholinesterase Inhibitor: From Galantamine to Natural Product.
    Zhang Z; Lv J; Wang Y; Yu H; Guo B; Zhai J; Wang C; Zhao Y; Fan F; Luo W
    Chemistry; 2023 May; 29(25):e202203363. PubMed ID: 36826395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.